{"id":"W2996325740","doi":"10.1158/1078-0432.ccr-19-2202","title":"Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"Grantová Agentura České Republiky; Cancer Research UK; Bloodwise; Kay Kendall Leukaemia Fund; Blood Cancer UK; Gilead Sciences","keywords":"Activator (genetics); Cancer research; Signal transduction; PI3K/AKT/mTOR pathway; Phosphatase; Chemistry; Medicine; Cell biology; Biology; Phosphorylation; Internal medicine; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00959863,0.0001102704,0.0003266258,0.00007873301,0.0000248801,0.00001067719,0.0002418036,0.0002520943,0.0001216857],"category_scores_gemma":[0.003193193,0.0001032856,0.0001581519,0.0002241495,0.0002398241,0.00001085015,0.0001979657,0.0002632457,0.000004265882],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005552421,"about_ca_system_score_gemma":0.0008894444,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001900721,"about_ca_topic_score_gemma":0.00005996183,"domain_scores_codex":[0.9971492,0.0004436589,0.0008795038,0.0005294589,0.000677611,0.000320512],"domain_scores_gemma":[0.9975625,0.0006929244,0.0002570849,0.000470393,0.0009236707,0.00009345962],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002732669,0.0007501742,0.009728458,0.0002177451,0.0000438098,3.9274e-7,0.00001610279,0.0006848202,0.9768113,0.0004710067,0.0007709244,0.007772623],"study_design_scores_gemma":[0.004488941,0.001206355,0.002375144,0.0002731956,0.00002293403,1.985047e-7,0.0000343017,0.001330622,0.9890716,0.0003066493,0.0007796362,0.0001103877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919823,0.005060209,0.0002895136,0.0001315312,0.000176558,0.001856706,0.000472363,0.00000279101,0.00002802049],"genre_scores_gemma":[0.9978756,0.0002633605,0.0009720434,0.00004983389,0.000175794,0.0003979881,0.000206204,0.00002251099,0.00003671606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01226036,"threshold_uncertainty_score":0.4211864,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2678696130637175,"score_gpt":0.5193038078117423,"score_spread":0.2514341947480248,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}